Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.

Journal: Cell

Published: 2020-07-13

DOI: 10.1016/j.cell.2020.06.044

Affiliations: 22

Authors: 28

Go to article
Institutions Share
Institute of Virology, UoC, Germany 0.23
Laboratory of Experimental Immunology, UoC, Germany 0.19
Institute for Virology, Uni Marburg, Germany 0.09
DZIF Partner Site Giessen-Marburg-Langen, Germany 0.09
Department of Structural Biology, WIS, Israel 0.07
Faculty of Medicine, JMU, Germany 0.04
University Hospital Tübingen (UKT), Uni Tübingen, Germany 0.04
Center for Internal Medicine, GU, Germany 0.04
University Hospital Frankfurt, GU, Germany 0.04
DZIF Partner Site Bonn-Cologne, Germany 0.03
Center for Molecular Medicine Cologne (CMMC), UoC, Germany 0.02
Cluster of Excellence - Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), UoC, Germany 0.02
Center for Integrated Oncology Aachen Bonn Köln Düsseldorf (CIO), Germany 0.02
Division of Infectious Diseases and Tropical Medicine, LMU, Germany 0.02
Städtisches Klinikum München Schwabing, Germany 0.02
Department of Computer Science, Uni Tübingen, Germany 0.01
Faculty of Medicine, Uni Tübingen, Germany 0.01
Institute for Experimental Dentistry and Oral Musculoskeletal Biology, UoC, Germany 0.01
Center for Biochemistry, UoC, Germany 0.01
DZIF Partner Site Tübingen, Germany 0.01
Innere Medizin I - Onkologie, Hämatologie, Klinische Infektiologie, Klinische Immunologie, Hämostaseologie, Internistische Intensivmedizin, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER